Bharath Biotech COVAXIN Stage3 Trials To Commence Soon, Deets Inside
Category: Telangana
bharath-biotech-covaxin-stage3-trials-to-commence-soon-deets-inside_g2d

Hyderabad: While Bharat Biotech is making preparations for Covaxin Stage 3 clinical trials on more than 25,000 to 30,000 individuals as of October, phase 2 studies at NIMS are expected to be completed in two weeks. The first dose of the vaccine was given to 50 volunteers, with a second dose to be given after 21 days. A doctor involved in the process said that ten days had already passed before the first dose was given.

Telangana, meanwhile, has registered 2,296 new cases, pushing the cumulative infections to 1.77 lakh so far. Ten patients succumbed to the virus and the number of dead was 1062.

0 218
Posted Comments
FEEDBACK
@ galli2delhi.com All Rights Reserved
@ galli2delhi.com All Rights Reserved